These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 15539417)

  • 1. Acute adenosine preconditioning is mediated by p38 MAPK activation in discrete subcellular compartments.
    Ballard-Croft C; Kristo G; Yoshimura Y; Reid E; Keith BJ; Mentzer RM; Lasley RD
    Am J Physiol Heart Circ Physiol; 2005 Mar; 288(3):H1359-66. PubMed ID: 15539417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
    Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
    Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo adenosine receptor preconditioning reduces myocardial infarct size via subcellular ERK signaling.
    Reid EA; Kristo G; Yoshimura Y; Ballard-Croft C; Keith BJ; Mentzer RM; Lasley RD
    Am J Physiol Heart Circ Physiol; 2005 May; 288(5):H2253-9. PubMed ID: 15653762
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of p38 MAPK and AMPK restores adenosine-induced cardioprotection in hearts stressed by antecedent ischemia by altering glucose utilization.
    Jaswal JS; Gandhi M; Finegan BA; Dyck JR; Clanachan AS
    Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H1107-14. PubMed ID: 17496214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of p38 mitogen-activated protein kinase abolishes insulin-mediated myocardial protection against ischemia-reperfusion injury.
    Chai W; Wu Y; Li G; Cao W; Yang Z; Liu Z
    Am J Physiol Endocrinol Metab; 2008 Jan; 294(1):E183-9. PubMed ID: 18003719
    [TBL] [Abstract][Full Text] [Related]  

  • 6. p38 mitogen-activated protein kinase mediates adenosine-induced alterations in myocardial glucose utilization via 5'-AMP-activated protein kinase.
    Jaswal JS; Gandhi M; Finegan BA; Dyck JR; Clanachan AS
    Am J Physiol Heart Circ Physiol; 2007 Apr; 292(4):H1978-85. PubMed ID: 17172269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning.
    Marais E; Genade S; Strijdom H; Moolman JA; Lochner A
    J Mol Cell Cardiol; 2001 Dec; 33(12):2157-77. PubMed ID: 11735262
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion.
    Marais E; Genade S; Huisamen B; Strijdom JG; Moolman JA; Lochner A
    J Mol Cell Cardiol; 2001 Apr; 33(4):769-78. PubMed ID: 11273729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ischemic preconditioning activates MAPKAPK2 in the isolated rabbit heart: evidence for involvement of p38 MAPK.
    Nakano A; Baines CP; Kim SO; Pelech SL; Downey JM; Cohen MV; Critz SD
    Circ Res; 2000 Feb; 86(2):144-51. PubMed ID: 10666409
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of p38 mitogen-activated protein kinases in cardioprotection of morphine preconditioning.
    Zhang Y; Gu EW; Zhang J; Chen ZW
    Chin Med J (Engl); 2007 May; 120(9):777-81. PubMed ID: 17531118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylation of tyrosine 182 of p38 mitogen-activated protein kinase correlates with the protection of preconditioning in the rabbit heart.
    Weinbrenner C; Liu GS; Cohen MV; Downey JM
    J Mol Cell Cardiol; 1997 Sep; 29(9):2383-91. PubMed ID: 9299362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The p38 MAPK inhibitor, SB203580, abrogates ischaemic preconditioning in rat heart but timing of administration is critical.
    Mocanu MM; Baxter GF; Yue Y; Critz SD; Yellon DM
    Basic Res Cardiol; 2000 Dec; 95(6):472-8. PubMed ID: 11192368
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of a survival signal in the ischemic heart by resveratrol through p38 mitogen-activated protein kinase/mitogen- and stress-activated protein kinase 1/cAMP response element-binding protein signaling.
    Das S; Tosaki A; Bagchi D; Maulik N; Das DK
    J Pharmacol Exp Ther; 2006 Jun; 317(3):980-8. PubMed ID: 16525036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SB 203580, an inhibitor of p38 MAPK, abolishes infarct-limiting effect of ischemic preconditioning in isolated rabbit hearts.
    Nakano A; Cohen MV; Critz S; Downey JM
    Basic Res Cardiol; 2000 Dec; 95(6):466-71. PubMed ID: 11192367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of p38-mitogen-activated protein kinase in ischaemic preconditioning in rat heart.
    Bell JR; Eaton P; Shattock MJ
    Clin Exp Pharmacol Physiol; 2008 Feb; 35(2):126-34. PubMed ID: 17892505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed adenosine A1 receptor preconditioning in rat myocardium is MAPK dependent but iNOS independent.
    Lasley RD; Keith BJ; Kristo G; Yoshimura Y; Mentzer RM
    Am J Physiol Heart Circ Physiol; 2005 Aug; 289(2):H785-91. PubMed ID: 15833799
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of the cardiac p38-MAPK pathway by SB203580 delays ischemic cell death.
    Barancik M; Htun P; Strohm C; Kilian S; Schaper W
    J Cardiovasc Pharmacol; 2000 Mar; 35(3):474-83. PubMed ID: 10710135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SAPKs regulation of ischemic preconditioning.
    Sato M; Cordis GA; Maulik N; Das DK
    Am J Physiol Heart Circ Physiol; 2000 Sep; 279(3):H901-7. PubMed ID: 10993748
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of histone deacetylases triggers pharmacologic preconditioning effects against myocardial ischemic injury.
    Zhao TC; Cheng G; Zhang LX; Tseng YT; Padbury JF
    Cardiovasc Res; 2007 Dec; 76(3):473-81. PubMed ID: 17884027
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The noble gas xenon induces pharmacological preconditioning in the rat heart in vivo via induction of PKC-epsilon and p38 MAPK.
    Weber NC; Toma O; Wolter JI; Obal D; Müllenheim J; Preckel B; Schlack W
    Br J Pharmacol; 2005 Jan; 144(1):123-32. PubMed ID: 15644876
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.